MIRA PHARMACEUTICALS, INC.
Related Filers (14)
- Bay Shore Trust (9)
- Cappy George (3)
- McNulty Brian Patrick (3)
- Nicholoudis Christos (2)
- Chapman Christopher C JR (2)
- Aminov Erez (2)
- Yanez Michelle (2)
- Vorhoff David C (1)
- Kaplin Adam (1)
- McColl Hugh III (1)
- Tuck Talhia (1)
- Kroenig Bradley (1)
- Daly Brian Frederick (1)
- Jerman Michael Allen (1)
- Show More ...
Financials (2)
10-Q
Monday, 11/13/2023
Quarterly Report for period ending 2023-09-30
10-Q
Friday, 9/15/2023
Quarterly Report for period ending 2023-06-30
News (6)
8-K
Wednesday, 1/17/2024
Current report filing
8-K
Friday, 12/1/2023
Current report filing
8-K
Monday, 11/20/2023
Current report filing
8-K
Wednesday, 10/25/2023
Current report filing
8-K
Thursday, 8/31/2023
Current report filing
8-K
Monday, 8/7/2023
Current report filing
Other (12)
EFFECT
Wednesday, 12/27/2023
Notice of Effectiveness
CORRESP
Friday, 12/22/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 8/2/2023
Notice of Effectiveness
CORRESP
Monday, 7/31/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 7/31/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Monday, 7/31/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERT
Monday, 7/31/2023
Certification by an exchange approving securities for listing
CORRESP
Friday, 7/14/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 7/13/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 6/29/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Monday, 8/1/2022
Exempt (Private) Offering
D
Monday, 8/1/2022
Exempt (Private) Offering
Ownership (25)
4
Wednesday, 12/27/2023
Bay Shore Trust: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 12/27/2023
Bay Shore Trust: Major Shareholders
SC 13D/A
Monday, 11/20/2023
Bay Shore Trust: Major Shareholders
3
Monday, 11/20/2023
Jerman Michael Allen: Initial statement of beneficial ownership of securities
4
Friday, 11/17/2023
Bay Shore Trust: Statement of changes in beneficial ownership of securities
3
Friday, 11/3/2023
Daly Brian Frederick: Initial statement of beneficial ownership of securities
3
Thursday, 10/12/2023
McNulty Brian Patrick: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 10/12/2023
Bay Shore Trust: Major Shareholders
4
Thursday, 8/24/2023
Cappy George: Statement of changes in beneficial ownership of securities
4
Monday, 8/21/2023
Yanez Michelle: Statement of changes in beneficial ownership of securities
4
Monday, 8/21/2023
Aminov Erez: Statement of changes in beneficial ownership of securities
4
Monday, 8/21/2023
Chapman Christopher C JR: Statement of changes in beneficial ownership of securities
4
Monday, 8/21/2023
Nicholoudis Christos: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 8/14/2023
Bay Shore Trust: Major Shareholders
4
Friday, 8/4/2023
Cappy George: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/2/2023
Aminov Erez: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Vorhoff David C: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Nicholoudis Christos: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Yanez Michelle: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
McColl Hugh III: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Chapman Christopher C JR: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Kroenig Bradley: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Cappy George: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Tuck Talhia: Initial statement of beneficial ownership of securities
3
Wednesday, 8/2/2023
Kaplin Adam: Initial statement of beneficial ownership of securities
Prospectus (15)
S-1
Monday, 12/18/2023
General form of registration statement for all companies including face-amount certificate companies
424B3
Tuesday, 11/14/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Monday, 9/18/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B1
Friday, 8/4/2023
Prospectus filed pursuant to Rule 424(b)(1)
424B4
Friday, 8/4/2023
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Friday, 7/28/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 7/25/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 7/21/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 7/18/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 7/14/2023
General form of registration statement for all companies including face-amount certificate companies
S-1
Thursday, 6/29/2023
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Thursday, 6/8/2023
Correspondence Related to Draft Registration Statement
DRS/A
Thursday, 6/8/2023
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Tuesday, 5/2/2023
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Wednesday, 6/29/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy